دورية أكاديمية
Adherence with surveillance schedule in patients with invasive melanoma.
| العنوان: | Adherence with surveillance schedule in patients with invasive melanoma. |
|---|---|
| المؤلفون: | Shah H; Albany Medical College, 43 New Scotland Avenue, Albany, NY, 12208, USA., Feustel P; Albany Medical College, 43 New Scotland Avenue, Albany, NY, 12208, USA., Davis L; Albany Medical College, Department of Surgery, 50 New Scotland Avenue, Albany, NY, 12208, USA. Electronic address: davisl8@amc.edu. |
| المصدر: | Surgical oncology [Surg Oncol] 2023 Jun; Vol. 48, pp. 101943. Date of Electronic Publication: 2023 Apr 07. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 9208188 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-3320 (Electronic) Linking ISSN: 09607404 NLM ISO Abbreviation: Surg Oncol Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: Amsterdam : Elsevier Science Original Publication: Oxford ; Boston : Blackwell Scientific Publications, c1992- |
| مواضيع طبية MeSH: | Melanoma*/surgery , Neoplasms*/therapy, Humans ; Retrospective Studies ; Patient Care Planning ; Recurrence ; Melanoma, Cutaneous Malignant |
| مستخلص: | Background: Seven percent of patients develop melanoma recurrence after successful treatment, and 4-8% develop a second primary melanoma. This study aimed to assess how providing Survivorship Care Plans (SCPs) to patients may improve adherence to surveillance visits. Methods: All patients treated for invasive melanoma at our institution between 8/1/2018-2/29/2020 were included in this retrospective chart review. SCPs were delivered in-person to patients and sent to primary care providers and dermatologists. Logistic regression was performed to assess influences on adherence. Results: Of 142 patients, 73 (51.4%) received SCP regarding their follow-up care. Reception of SCP (p = 0.044) and shorter distance from clinic (p = 0.018) significantly improved rates of adherence. Seven patients developed melanoma recurrences, five were physician-detected. Three patients had primary site recurrence, six had lymph node recurrences, and three had distant recurrences. There were 5 second primaries, all physician-detected. Conclusion: Our study is the first to investigate the impact of SCPs on patient adherence in melanoma survivors and the first to reveal a positive correlation between SCPs and adherence in any type of cancer. Melanoma survivors require close clinical follow-up, as demonstrated by our study finding that even with SCPs, most recurrences and all new primary melanomas were physician-detected. Competing Interests: Declaration of competing interest None declared. (Copyright © 2023 Elsevier Ltd. All rights reserved.) |
| فهرسة مساهمة: | Keywords: Active surveillance; Cancer survivorship; Follow-up care; Melanoma; Patient adherence |
| تواريخ الأحداث: | Date Created: 20230413 Date Completed: 20230523 Latest Revision: 20231213 |
| رمز التحديث: | 20231215 |
| DOI: | 10.1016/j.suronc.2023.101943 |
| PMID: | 37054530 |
| قاعدة البيانات: | MEDLINE |
Full Text via ClinicalKey 
Full Text Finder | تدمد: | 1879-3320 |
|---|---|
| DOI: | 10.1016/j.suronc.2023.101943 |